CCR5 and Hepatic fibrosis: Cenicriviroc is a dual antagonist of CCR2 and CCR5, It has been proven to alleviate liver fibrosis in mice [25], and its anti-fibrotic effect has been demonstrated in the clinical data of phase IIb [26].